SMI Adviser

SMI Adviser



Free

1.4for iPhone, iPod touch
9.9
12 Ratings
American Psychiatric Association
Developer
63.8 MB
Size
Mar 26, 2024
Update Date
Medical
Category
17+
Age Rating
Age Rating
4+
Apps in this category do not contain restricted content.
9+
Apps in this category may contain mild or occasional cartoon, fantasy or real-life violence, as well as occasional or mild adult, sexually suggestive or horrifying content and may not be suitable for children under 9 years of age.
12+
Apps in this category may contain occasional mild indecent language, frequent or intense cartoon or real-life violence, minor or occasional adult or sexually suggestive material, and simulated gambling, and may be for children under 12 years of age.
17+
You must be at least 17 years old to access this App.
Apps in this category may contain frequent and intense offensive language; Frequent and intense cartoon, fantasy or realistic violence: frequent and intense adult, scary and sexually suggestive subjects: as well as sexual content, nudity, tobacco, alcohol and drugs, may not be suitable for children under 17 years of age.
SMI Adviser Screenshots
SMI Adviser posterSMI Adviser posterSMI Adviser posterSMI Adviser posterSMI Adviser posterSMI Adviser poster

About SMI Adviser

Submit questions, access resources, and receive guidance from national experts in SMI.

Our mission is to advance the use of a person-centered approach to care that ensures people who have SMI find the treatment and support they need. For clinicians, we offer access to education, data, and consultations so you can make evidence-based treatment decisions. For individuals, families, friends, people who have questions, or people who care for someone with SMI, we offer access to resources and answers from a national network of experts. SMI Adviser is funded by the Substance Abuse and Mental Health Services Administration (SAMHSA) and administered by the American Psychiatric Association (APA).

Funding for this initiative was made possible (in part) by Grant No. 1H79SM080818-01 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

*****

SMI Adviser is provided for general educational and informational purposes. It should not be construed as medical advice in connection with the care of a particular patient or as a statement of the standard of care. It is not necessarily inclusive of all potential treatments. The activities and materials offered through SMI Adviser should not be considered as providing the basis for any certification or authorization to prescribe or administer medication. SMI Adviser is not intended to be a substitute for independent professional medical advice, diagnosis or treatment. SMI Adviser does not endorse or recommend any pharmaceutical or other treatment as an appropriate course for any particular patient or condition. The advice of a physician or other qualified health provider should be obtained for a treatment recommendation or to answer any questions regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read or seen on SMI Adviser. SMI Adviser is provided as-is and is not guaranteed to be correct, complete or current. APA makes no warranty, expressed or implied, about the accuracy, applicability, fitness, completeness or reliability of the information contained within SMI Adviser. APA assumes no responsibility for any injury or damage to persons or property arising out of or related to any use of SMI Adviser or for any errors or omissions. The limitations applicable to the SMI Adviser consultation feature are set forth at: https://smiadviser.org/limitations-of-consultation
Show More

What's New in the Latest Version 1.4

Last updated on Mar 26, 2024
Old Versions
- New interactive tool for clinicians: App Evaluation Screener
Show More
Version History
1.4
Mar 26, 2024
- New interactive tool for clinicians: App Evaluation Screener
1.3.4
Dec 22, 2023
- Updates to LAI dose conversion tool
1.3.3
Aug 17, 2023
- Updated conversion information for Risperidone in LAI Conversion Tool
1.3.2
Aug 10, 2023
- New tool to help predict clozapine level and dose needed to achieve that level based on smoking status, sex, weight, and age.
1.3.1
Jun 15, 2023
- New tool to convert oral to long-acting injectable antipsychotics.
1.3
May 10, 2023
- Improved education catalog
1.2.7
Dec 1, 2022
- Bug Fixes
1.2.6
Jul 15, 2022
- Bug Fixes
1.2.5
Apr 13, 2022
- Added new Questionnaire: Alcohol Use Disorders Identification Test-Concise (AUDIT-C).
- Added PDF sharing functionality for all Questionnaires.
1.2.4
Dec 2, 2021
- Minor Bug Fixes
1.2.3
Aug 5, 2021
- AIMS Rating Scale
- Bug Fixes
1.2.2
Aug 20, 2020
- Bug Fixes
1.2.1
Dec 31, 2019
- Bug Fixes
1.2
Dec 20, 2019
- Rating scale DAST-10
- Rating scale PROMIS-V1.2
1.1.3
Nov 18, 2019
- Performance Improvements
1.1.2
Nov 1, 2019
- Global Search in Education Catalog and Knowledge Base
- Bug Fixes
1.1
Sep 25, 2019
Performance improvements and bug fixes.
1.0
Sep 16, 2019

SMI Adviser FAQ

Click here to learn how to download SMI Adviser in restricted country or region.
Check the following list to see the minimum requirements of SMI Adviser.
iPhone
Requires iOS 12.0 or later.
iPod touch
Requires iOS 12.0 or later.
SMI Adviser supports English

SMI Adviser Alternative

You May Also Like

Get more from American Psychiatric Association